Rhizen Pharma gets USFDA approval for phase one clinical trials for COVID-19 drug

New Delhi, Rhizen Pharmaceuticals, an associate company of Alembic Pharmaceuticals, on Wednesday said it has received approval from the US health regulator to commence phase one clinical trials on retroviral … Read More

Exit mobile version